A study to compare how hydrochlorothiazide tablets work in healthy volunteers
- Substances:Hydrochlorothiazide
Spain- Participants:18–64 years · Healthy volunteers
- Substances:Hydrochlorothiazide
- Sponsor:Laboratorios Normon S.A.
Rare diseases
Investigational molecules
Locations
Back to Spain3 275 clinical trials in Majadahonda, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
SpainPhase 1 safety and dose-finding study of NG-350A plus pembrolizumab in patients with metastatic cancer
SpainA Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
SpainEvaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study
Spain
SpainEfficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients
SpainBioavailability Study of Oral Minoxidil 1 mg Tablet Compared with Topical Minoxidil Solution in Healthy Volunteers with Androgenetic Alopecia
SpainComparison of montelukast 10 mg capsules and montelukast 10 mg film-coated tablets in healthy volunteers to evaluate how the medicine is absorbed.
SpainBioequivalence Study of Linagliptin 5 mg Film‑Coated Tablets in Healthy Volunteers for Diabetes Treatment
SpainPhase 1 Study of ADCT-901 in Patients with Advanced Solid Tumors to Evaluate Safety, Tolerability, Pharmacokinetics and Antitumor Activity
SpainA study to compare the absorption of apixaban capsules and apixaban tablets in healthy volunteers to prevent thrombosis.
SpainPhase 1/2 Evaluation of Zilovertamab Vedotin in PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on ATTR amyloid cardiomyopathy, evaluating new therapeutic approaches for both hereditary and wild-type variants of this heart condition.
Multiple trials testing novel compounds to improve patient outcomes and quality of life.
Comprehensive vaccine development programs targeting urinary tract infections and various herpes virus strains, including studies on both prevention and treatment.
Focus on long-term efficacy and immune response in different age groups.
Advanced research in multiple cancer types, including prostate cancer, gastric cancer, and lymphomas, with emphasis on targeted therapies and combination treatments.
Investigating breakthrough treatments for various stages of cancer progression.
Pioneering research in cerebral ischemic stroke and multiple sclerosis, evaluating innovative treatments to improve patient outcomes and disease management.
Focus on both acute interventions and long-term disease modification.
Tell us about your condition – we search every trial in Europe and connect you with the right site.